Latest News & Features
Big Pharma
An attempt to obtain a supplementary protection certificate ended up raising the bar to achieving this coveted IP, as Joel Beevers and Michael Pears of Potter Clarkson explain. 10 July 2020
Big Pharma
The rush to open access to IP-protected tech, medicines and devices in the fight against COVID-19 could cause problems later, argues MaryAnne Armstrong of Birch, Stewart, Kolasch & Birch. 10 July 2020
Biotechnology
The COVID-19 pandemic poses unprecedented challenges to the biomedical community as it strives to find the best solutions to fight COVID-19. 10 July 2020
Americas
The antitrust chief of the US Justice Department (DOJ) made a rare appearance in court when he requested that the US Court of Appeals for the Eleventh Circuit reject a defence used by a medical and dental board against an antitrust lawsuit. 9 July 2020
Americas
In the high stakes world of life sciences, the strength of a company’s IP portfolio can determine the value of a corporate transaction, argue Jonathan Harris and Nisan Zaghi of Axinn, and Ian Lodovice of Biogen. 9 July 2020
Europe
Drug company Teva has lost an appeal over its bid to trademark two word signs, after the tenth chamber of the EU General Court ruled in favour of the European Union IP Office (EUIPO) yesterday, July 8. 9 July 2020
article
Amid confusion over patent eligibility, US life sciences IP owners should consider trade secret law when building their IP protection strategy, argues John A Stone of DeCotiis, FitzPatrick, Cole & Giblin. 9 July 2020
Biotechnology
A Roche subsidiary will be unable to block Amgen from producing the cancer drug Mvasi (bevacizumab), the Court of Appeals for the Federal Circuit has ruled. 7 July 2020
article
Jakob Wested is currently working on repurposing of medicine with Johnathan Liddicoat from Cambridge which has some interesting perspectives around the current COVID situation. Jakob's contribution will touch upon issues of patenting second medical use as well as the complementarity between IPR and regulatory exclusivities. 7 July 2020
Europe
The European Patent Office has unveiled data sets relating to antiviral vaccines and pharmaceutical therapeutics as part of its new “Fighting coronavirus” platform. 6 July 2020